-
Syngene announces Q1 FY21 results; Revenue stands at Rs. 437 Cr
expresspharma
July 24, 2020
The company posted quarterly revenue of Rs. 437 Cr, in line with guidance: Profit After Tax, was impacted less than expected, at Rs. 58 Cr for the quarter.
-
Morepen Labs clocks double-digit growth in its sales and net profit in FY 2019-20
expresspharma
June 24, 2020
Consolidated Profit before Tax (PBT) recorded extraordinary growth by 34 per cent at Rs. 39.11 crore, up from Rs. 29.18 crore in the previous fiscal.
-
Clariant Chemicals Q4 financial result: Sales up by 5.4 per cent to Rs. 757.3 crores
expresspharma
June 19, 2020
The net profit stood at Rs. 71 crores as against Rs. 30 crores in the corresponding previous year.
-
Lupin Q4 net profit rises 35 pc to Rs 390 cr
expresspharma
June 01, 2020
The company had posted a net profit of Rs 289.56 crore for the corresponding period of the previous fiscal, Lupin said in a late night filing.
-
Sun Pharma reports 59 per cent fall in consolidated profit
expresspharma
May 29, 2020
The slump in profits was largely attributed to the Rs 260 crore settlement charges paid by the company to the Department of Justice in the USA and increasing expenses.
-
Syngene Intl gains after Q4 PAT rises 20 per cent to Rs 120 cr
expresspharma
May 14, 2020
Syngene's consolidated EBITDA jumped 24 per cent to Rs 225 crore in Q4 March 2020 from Rs 181 crore in Q4 March 2019.
-
Wockhardt Q4 results: Firm posts profit of Rs 69 crore after loss in Q4FY19
expresspharma
May 12, 2020
Consolidated total income of the company stood at Rs 700.66 crore for the quarter under review. It was Rs 866.76 crore in the year-ago period.
-
AZ delivers strong first quarter
pharmatimes
May 05, 2020
AstraZeneca says it has delivered “a quarter of strong revenue and profit growth, reflecting the immense efforts of supply chain, commercial and other colleagues around the world to get vital medicines to patients”.
-
Novartis sales, profits rise in first quarter on COVID-19 buying rush
expresspharma
April 29, 2020
The result topped Novartis’s 2020 forecast of mid to high single-digit percentage growth for revenue and high single-digit to low double-digit growth for operating profit.
-
Sun Pharma reports Q1 net profit at Rs.1,387
biospectrumasia
August 15, 2019
Sun Pharmaceutical Industries Ltd. reported financials for the first quarter ending June 30th, 2019.